ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.


Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 2 9 2019
medline: 12 9 2020
entrez: 2 9 2019
Statut: ppublish

Résumé

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Identifiants

pubmed: 31473267
pii: S1071-9164(19)31398-3
doi: 10.1016/j.cardfail.2019.08.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

854-865

Subventions

Organisme : British Heart Foundation
ID : FS/10/40/28260
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/12/56/29723
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/16/31/32185
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/21/33447
Pays : United Kingdom

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Sharmila Dorbala (S)

Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: sdorbala@bwh.harvard.edu.

Yukio Ando (Y)

Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Sabahat Bokhari (S)

Columbia University Medical Center, Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, New York.

Angela Dispenzieri (A)

Divisions of Hematology and Cardiovascular Diseases, Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Rodney H Falk (RH)

Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Victor A Ferrari (VA)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Marianna Fontana (M)

Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.

Olivier Gheysens (O)

Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.

Julian D Gillmore (JD)

Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.

Andor W J M Glaudemans (AWJM)

Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Mazen A Hanna (MA)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Bouke P C Hazenberg (BPC)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Arnt V Kristen (AV)

Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Raymond Y Kwong (RY)

Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Mathew S Maurer (MS)

Columbia University Medical Center, Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, New York.

Giampaolo Merlini (G)

Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Edward J Miller (EJ)

Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.

James C Moon (JC)

Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.

Venkatesh L Murthy (VL)

Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, Michigan.

C Cristina Quarta (CC)

Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.

Claudio Rapezzi (C)

Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.

Frederick L Ruberg (FL)

Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts.

Sanjiv J Shah (SJ)

Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Riemer H J A Slart (RHJA)

Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Hein J Verberne (HJ)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Jamieson M Bourque (JM)

Cardiovascular Imaging Center, Departments of Medicine and Radiology, University of Virginia, Charlottesville, Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH